INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 214 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.82 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $76,399 | -47.4% | 93,170 | 0.0% | 0.00% | – |
| Q4 2022 | $145,345 | -91.8% | 93,170 | -91.0% | 0.00% | -100.0% |
| Q3 2022 | $1,780,566 | +1171.8% | 1,032,212 | +1177.3% | 0.00% | – |
| Q2 2022 | $140,000 | -51.7% | 80,813 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $290,000 | -28.0% | 80,813 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $403,000 | -30.9% | 80,813 | -0.7% | 0.00% | 0.0% |
| Q3 2021 | $583,000 | -22.8% | 81,409 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $755,000 | -0.7% | 81,409 | -0.5% | 0.00% | -50.0% |
| Q1 2021 | $760,000 | +25.6% | 81,850 | +19.7% | 0.00% | +100.0% |
| Q4 2020 | $605,000 | -1.9% | 68,396 | +28.6% | 0.00% | 0.0% |
| Q3 2020 | $617,000 | -54.1% | 53,172 | +6.7% | 0.00% | -66.7% |
| Q2 2020 | $1,343,000 | +274.1% | 49,823 | +3.2% | 0.00% | +200.0% |
| Q1 2020 | $359,000 | +123.0% | 48,262 | -1.3% | 0.00% | – |
| Q4 2019 | $161,000 | +101.2% | 48,918 | +25.3% | 0.00% | – |
| Q3 2019 | $80,000 | -30.4% | 39,053 | 0.0% | 0.00% | – |
| Q2 2019 | $115,000 | -9.4% | 39,053 | +14.3% | 0.00% | – |
| Q1 2019 | $127,000 | -7.3% | 34,165 | 0.0% | 0.00% | – |
| Q4 2018 | $137,000 | -22.6% | 34,165 | +7.0% | 0.00% | – |
| Q3 2018 | $177,000 | +41.6% | 31,916 | 0.0% | 0.00% | – |
| Q2 2018 | $125,000 | -26.0% | 31,916 | -11.2% | 0.00% | – |
| Q1 2018 | $169,000 | +14.2% | 35,933 | 0.0% | 0.00% | – |
| Q4 2017 | $148,000 | -35.1% | 35,933 | 0.0% | 0.00% | – |
| Q3 2017 | $228,000 | -7.3% | 35,933 | +14.4% | 0.00% | -100.0% |
| Q2 2017 | $246,000 | +34.4% | 31,407 | +13.8% | 0.00% | – |
| Q1 2017 | $183,000 | -4.7% | 27,603 | 0.0% | 0.00% | – |
| Q4 2016 | $192,000 | -25.3% | 27,603 | 0.0% | 0.00% | – |
| Q3 2016 | $257,000 | +0.8% | 27,603 | 0.0% | 0.00% | -100.0% |
| Q2 2016 | $255,000 | +6.2% | 27,603 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $240,000 | +29.7% | 27,603 | 0.0% | 0.00% | – |
| Q4 2015 | $185,000 | +15.6% | 27,603 | 0.0% | 0.00% | – |
| Q3 2015 | $160,000 | -44.6% | 27,603 | -22.0% | 0.00% | -100.0% |
| Q2 2015 | $289,000 | 0.0% | 35,380 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $289,000 | -11.1% | 35,380 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $325,000 | -6.6% | 35,380 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $348,000 | -8.9% | 35,380 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $382,000 | – | 35,380 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Triatomic Management LP | 235,000 | $405,000 | 0.23% |
| Green Alpha Advisors, LLC | 147,380 | $254,000 | 0.22% |
| Financial Advocates Investment Management | 14,161 | $628,000 | 0.05% |
| Virtus ETF Advisers LLC | 72,540 | $125,000 | 0.05% |
| Cedar Brook Financial Partners, LLC | 88,750 | $153,094 | 0.05% |
| Rafferty Asset Management, LLC | 2,363,189 | $4,077,000 | 0.04% |
| Hennion & Walsh Asset Management, Inc. | 352,721 | $608,000 | 0.04% |
| CAXTON ASSOCIATES LP | 130,728 | $226,000 | 0.03% |
| Keystone Financial Group | 74,058 | $128,000 | 0.03% |
| Virtu Financial LLC | 130,829 | $226,000 | 0.02% |